Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Epistasis Analysis01:09

Epistasis Analysis

Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis.

JTO clinical and research reports·2025
Same author

Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations.

Therapeutic advances in medical oncology·2024
Same author

The effect of body mass index at diagnosis on survival of patients with squamous cell head and neck carcinoma.

American journal of cancer research·2024
Same author

Respiratory Function as a Prognostic Factor for Lung Cancer in Screening and General Populations.

Annals of the American Thoracic Society·2024
Same author

Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study.

Current oncology (Toronto, Ont.)·2024
Same author

Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer.

Pharmacoepidemiology and drug safety·2024
Same journal

Abstracts from Specialized Centers of Research Excellence (SCORE) on Sex Differences 2025 annual meeting.

BMC proceedings·2026
Same journal

Conference abstracts the 1st UDOM scientific conference on health: healthy lives and well-being for all: opportunities and challenges.

BMC proceedings·2026
Same journal

Entrepreneurship beyond the lab: commercializing your creative outputs.

BMC proceedings·2026
Same journal

The need to strengthen laboratory leadership, systems, and networks to enhance outbreak detection and resilience in Africa: proceedings of a regional workshop.

BMC proceedings·2026
Same journal

Abstracts from the Globesync Community Research and Sustainability 2025 (GlobeCoReS 2025).

BMC proceedings·2026
Same journal

Bauru International Craniofacial Symposium: Comprehensive Care, Policy and Advocacy Proceedings.

BMC proceedings·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

A pathway-based association analysis model using common and rare variants.

Lu Cheng1, Pingzhao Hu, Jenna Sykes

  • 1Department of Biostatistics, Princess Margaret Hospital, 610 University Ave,, Toronto, ON M5G 2M9, Canada. wxu@uhnres.utoronto.ca.

BMC Proceedings
|March 1, 2012
PubMed
Summary
This summary is machine-generated.

This study introduces a new genetic model combining common and rare variants to analyze disease susceptibility. The model identified disease-associated pathways, finding common variants had a stronger genetic effect than rare ones.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Related Experiment Videos

Last Updated: May 24, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Area of Science:

  • Genetics
  • Statistical Genetics
  • Bioinformatics

Background:

  • Investigating combined genetic effects on disease susceptibility is crucial.
  • Genome-wide association studies often struggle to identify causal variants.
  • Rare variant models are proposed to address limitations in common variant analysis.

Purpose of the Study:

  • To develop and apply a pathway-based genetic association model incorporating both common and rare variants.
  • To explore the combined impact of multiple rare variants on disease susceptibility.
  • To analyze genetic association with disease status in a simulated dataset.

Main Methods:

  • Constructed a pathway-based genetic association model.
  • Integrated both common and rare genetic variants into the analysis.
  • Applied the model to unrelated individuals from a simulated dataset (Genetic Analysis Workshop 17, Replication 1).

Main Results:

  • Identified several pathways potentially associated with disease status.
  • Demonstrated that common variants exhibited a stronger genetic effect compared to rare variants.
  • The model effectively analyzed combined genetic effects in disease susceptibility.

Conclusions:

  • The proposed pathway-based model effectively integrates common and rare variants for genetic association analysis.
  • Common variants appear to play a more significant role in genetic effect than rare variants in this context.
  • This approach offers a novel method for understanding complex genetic contributions to disease.